Blepharoptosis Repair for Drooping Eyelid

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Drooping Eyelid+1 MoreBlepharoptosis Repair - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether injecting local anesthetic through the back of the eyelid reduces pain during a common surgical procedure to fix droopy eyelids.

Eligible Conditions
  • Drooping Eyelid
  • Droopy Eyelid

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 6 Years

6 Years
0-10 Numerical Pain Scale
Post-Operative margin-reflex distance 1
Presence of post-operative lagophthalmos/fluorescein staining

Trial Safety

Trial Design

2 Treatment Groups

Subcut. + Subconj. Injection
1 of 2
Subcut. + Sham Subconj. Injection
1 of 2

Experimental Treatment

Non-Treatment Group

100 Total Participants · 2 Treatment Groups

Primary Treatment: Blepharoptosis Repair · Has Placebo Group · N/A

Subcut. + Subconj. InjectionExperimental Group · 2 Interventions: Subcut. + Subconj. Xylocaine, Blepharoptosis Repair · Intervention Types: Drug, Procedure
Subcut. + Sham Subconj. InjectionShamComparator Group · 2 Interventions: Blepharoptosis Repair, Subcut. + Sham Subconj. Injection · Intervention Types: Procedure, Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 years

Who is running the clinical trial?

University of ManitobaLead Sponsor
540 Previous Clinical Trials
187,062 Total Patients Enrolled
Matthew Lee-Wing, MDPrincipal InvestigatorUniversity of Manitoba

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are 18 years of age or older and able to give informed consent in English.
You have blepharoptosis undergoing repair using an anterior approach.